Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Communication Services | 10.92% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
LeMaitre Vascular
LMAT
$1.87B
| $1.93M | ﹤0.01% |
39,500
+600
| +2% | +$28.1K |
|
2027
Coherus Oncology
CHRS
$176M
| $1.92M | ﹤0.01% |
131,700
+3,100
| +2% | +$52.6K |
|
2028
Enanta Pharmaceuticals
ENTA
$391M
| $1.92M | ﹤0.01% |
39,000
+500
| +1% | +$24.9K |
|
2029
Standard Motor Products
SMP
$870M
| $1.92M | ﹤0.01% |
46,200
+700
| +2% | +$29.7K |
|
|
COWN
2030
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.92M | ﹤0.01% |
54,625
-1,900
| -3% | -$61.2K |
|
2031
OraSure Technologies
OSUR
$277M
| $1.91M | ﹤0.01% |
163,900
+2,100
| +1% | +$25.7K |
|
2032
SiTime
SITM
$20.7B
| $1.91M | ﹤0.01% |
19,400
+500
| +3% | +$58.5K |
|
2033
Univest Financial
UVSP
$1.19B
| $1.91M | ﹤0.01% |
66,878
+1,400
| +2% | +$35.5K |
|
|
KNL
2034
DELISTED
Knoll, Inc.
KNL
| $1.9M | ﹤0.01% |
114,800
| – | – |
|
2035
Perdoceo Education
PRDO
$1.99B
| $1.89M | ﹤0.01% |
158,300
+1,700
| +1% | +$21.5K |
|
|
ECHO
2036
DELISTED
Echo Global Logistics, Inc.
ECHO
| $1.89M | ﹤0.01% |
60,200
| – | – |
|
|
RUTH
2037
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.88M | ﹤0.01% |
75,800
+800
| +1% | +$17K |
|
2038
Vanda Pharmaceuticals
VNDA
$304M
| $1.88M | ﹤0.01% |
125,000
+1,400
| +1% | +$22.7K |
|
|
SII
2039
Sprott
SII
$3.03B
| $1.87M | ﹤0.01% |
49,175
| – | – |
|
|
PLYA
2040
DELISTED
Playa Hotels & Resorts
PLYA
| $1.86M | ﹤0.01% |
255,200
+102,200
| +67% | +$674K |
|
2041
Celldex Therapeutics
CLDX
$3.35B
| $1.86M | ﹤0.01% |
90,400
+1,900
| +2% | +$43.6K |
|
2042
Banc of California
BANC
$3.11B
| $1.85M | ﹤0.01% |
102,400
+1,100
| +1% | +$20.4K |
|
|
QADA
2043
DELISTED
QAD Inc.
QADA
| $1.85M | ﹤0.01% |
27,800
+700
| +3% | +$46.9K |
|
2044
Arcturus Therapeutics
ARCT
$223M
| $1.85M | ﹤0.01% |
44,800
+700
| +2% | +$41.7K |
|
2045
Astrana Health
ASTH
$1.87B
| $1.85M | ﹤0.01% |
68,244
+2,100
| +3% | +$50.5K |
|
2046
Stoneridge
SRI
$201M
| $1.85M | ﹤0.01% |
58,100
| – | – |
|
|
OGI
2047
Organigram Holdings
OGI
$177M
| $1.84M | ﹤0.01% |
133,250
+4,225
| +3% | +$48.8K |
|
2048
DMC Global
BOOM
$153M
| $1.83M | ﹤0.01% |
33,800
+400
| +1% | +$23K |
|
2049
Washington Trust Bancorp
WASH
$767M
| $1.83M | ﹤0.01% |
35,500
+600
| +2% | +$29.1K |
|
|
PING
2050
DELISTED
Ping Identity Holding Corp.
PING
| $1.83M | ﹤0.01% |
83,400
+2,000
| +2% | +$56.4K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.